Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0620
+0.0020 (3.33%)
Nov 11, 2026, 3:12 PM AEDT
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 70.92 million as of November 10, 2026. It is the 30,003rd most valuable company in the world and the 678th biggest in Australia. Its market cap has increased by 40.51% in one year.
Market Cap
70.92M
Enterprise Value
62.09M
Revenue
3.45M
Global Rank
Country Rank
#678 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 70.92M, an increase of 1,138.86%. That is a compound annual growth rate of 9.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 70.92M | -19.71% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 129.09M |
| Nyrada | 126.27M |
| Recce Pharmaceuticals | 107.02M |
| Island Pharmaceuticals | 94.75M |
| LTR Pharma | 84.76M |
| Arovella Therapeutics | 61.65M |
| Alterity Therapeutics | 60.71M |
| Entropy Neurodynamics | 47.37M |